About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Fostm5.1Wag
targeted mutation 5.1, Erwin F Wagner
MGI:5142240
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
 		Fostm5.1Wag/Fostm5.1Wag involves: 129P2/OlaHsd * C57BL/6 * SJL MGI:5142263
cx2
 		Egfrwa2/Egfr+
Fostm5.1Wag/Fostm5.1Wag
Tg(KRT5-SOS1)892A6Wag/0 		involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL MGI:5142267


Genotype
MGI:5142263
hm1
Allelic
Composition		 Fostm5.1Wag/Fostm5.1Wag
Genetic
Background		 involves: 129P2/OlaHsd * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fostm5.1Wag mutation (0 available); any Fos mutation (42 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
immune system
abnormal osteoclast differentiation ( J:175064 )
• osteoclast differentiation in bone marrow cultures is decreased compared to in wild-type cultures
decreased osteoclast cell number ( J:175064 )
• at 4 weeks of age
decreased interleukin-10 secretion ( J:175064 )
• from LPS-treated bone marrow macrophages
increased interleukin-6 secretion ( J:175064 )
• from LPS-treated bone marrow macrophages
increased tumor necrosis factor secretion ( J:175064 )
• from LPS-treated bone marrow macrophages
increased susceptibility to endotoxin shock ( J:175064 )
• LPS-treated bone marrow macrophages exhibit increased TNF-alpha and IL6 but decreased IL10 production compared with similarly treated wild-type cells
• LPS-treated mice exhibit increased TNF-alpha serum levels compared with similarly treated wild-type mice

skeleton
abnormal osteoclast differentiation ( J:175064 )
• osteoclast differentiation in bone marrow cultures is decreased compared to in wild-type cultures
decreased osteoclast cell number ( J:175064 )
• at 4 weeks of age
increased bone volume ( J:175064 )
• at 4, 12, and 25 weeks of age
decreased osteoblast cell number ( J:175064 )
• in bone marrow cultures
increased bone trabecula number ( J:175064 )
• at 12 weeks of age

homeostasis/metabolism

hematopoietic system
abnormal osteoclast differentiation ( J:175064 )
• osteoclast differentiation in bone marrow cultures is decreased compared to in wild-type cultures
decreased osteoclast cell number ( J:175064 )
• at 4 weeks of age

cellular
abnormal osteoclast differentiation ( J:175064 )
• osteoclast differentiation in bone marrow cultures is decreased compared to in wild-type cultures




Genotype
MGI:5142267
cx2
Allelic
Composition		 Egfrwa2/Egfr+
Fostm5.1Wag/Fostm5.1Wag
Tg(KRT5-SOS1)892A6Wag/0
Genetic
Background		 involves: 129P2/OlaHsd * C57BL/6 * CBA * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Egfrwa2 mutation (3 available); any Egfr mutation (85 available)
Fostm5.1Wag mutation (0 available); any Fos mutation (42 available)
Tg(KRT5-SOS1)892A6Wag mutation (0 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
neoplasm
decreased tumor growth/size ( J:175064 )
• at 4 weeks, tumor volume is decreased 50% compared to in Tg(KRT5-SOS1)892A6Mka mice

integument




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/23/2024
MGI 6.23 		The Jackson Laboratory